דאלאצין % 2 קרם וגינלי
pfizer pfe pharmaceuticals israel ltd - clindamycin phosphate - קרם - clindamycin phosphate 2 %w/w - clindamycin - clindamycin - treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.
דאלאצין פתילות ואגינליות
pfizer pfe pharmaceuticals israel ltd - clindamycin as phosphate - פתילות - clindamycin as phosphate 100 mg - clindamycin - clindamycin - dalacin vaginal ovules are indicated for 3-day treatment of bacterial vaginosis in non-pregnant women.
דיפרוספאן זריקה
organon pharma israel ltd., israel - betamethasone as dipropionate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone sodium phosphate 2 mg/ml; betamethasone as dipropionate 5 mg/ml - betamethasone - betamethasone - produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.
צלסטון כרונודוז
organon pharma israel ltd., israel - betamethasone acetate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone acetate 3 mg/ml; betamethasone sodium phosphate 3.945 mg/ml - betamethasone - betamethasone - indicated in the management of conditions known to be responsive to corticosteroid therapy.
ג'קאבי 5 מג
novartis israel ltd - ruxolitinib as phosphate - טבליה - ruxolitinib as phosphate 5 mg - ruxolitinib - ruxolitinib - jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.
ג'קאבי 15 מג
novartis israel ltd - ruxolitinib as phosphate - טבליה - ruxolitinib as phosphate 15 mg - ruxolitinib - ruxolitinib - jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.
ג'קאבי 20 מג
novartis israel ltd - ruxolitinib as phosphate - טבליה - ruxolitinib as phosphate 20 mg - ruxolitinib - ruxolitinib - jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.
רוקסט
taro pharmaceutical industries ltd - caffeine; codeine phosphate; paracetamol - קפליות - paracetamol 500 mg; caffeine 30 mg; codeine phosphate 10 mg - paracetamol - paracetamol - for the relief of pain and coughs and for the reduction of fever accompanied by pain.
רוקסט פלוס
taro pharmaceutical industries ltd - caffeine anhydrous; codeine phosphate; paracetamol - קפליות - paracetamol 500 mg; caffeine anhydrous 50 mg; codeine phosphate 15 mg - paracetamol, combinations excl. psycholeptics - paracetamol, combinations excl. psycholeptics - for the relief of pain and coughs and for the reduction of fever accompanied by pain.
רקוד טבליות
rekah pharmaceutical industry ltd, israel - codeine phosphate - טבליה - codeine phosphate 20 mg - codeine - codeine - antitussive, analgesic.